about
Surfactant phospholipid metabolismSphingolipids as cell fate regulators in lung development and diseaseSphingosine 1-phosphate receptor agonists: a patent review (2010-2012)Lipidomics reveals dramatic lipid compositional changes in the maturing postnatal lungSphingosine kinase-1 (SphK-1) regulates Mycobacterium smegmatis infection in macrophagesWhy is effective treatment of asthma so difficult? An integrated systems biology hypothesis of asthmaS1P2 receptor-dependent Rho-kinase activation mediates vasoconstriction in the murine pulmonary circulation induced by sphingosine 1-phosphateActin cytoskeleton regulates stretch-activated Ca2+ influx in human pulmonary microvascular endothelial cells.Lung injury and cancer: Mechanistic insights into ceramide and EGFR signaling under cigarette smoke.The multiMiR R package and database: integration of microRNA-target interactions along with their disease and drug associationsIntegrative genetic analysis of allergic inflammation in the murine lungLysophosphatidic acid-activated Cl- current activity in human systemic sclerosis skin fibroblastsMembranes in balance: mechanisms of sphingolipid homeostasis.Prolonged exposure to sphingosine 1-phosphate receptor-1 agonists exacerbates vascular leak, fibrosis, and mortality after lung injury.Lung injury and lung cancer caused by cigarette smoke-induced oxidative stress: Molecular mechanisms and therapeutic opportunities involving the ceramide-generating machinery and epidermal growth factor receptor.Metabolic consequences of sepsis-induced acute lung injury revealed by plasma ¹H-nuclear magnetic resonance quantitative metabolomics and computational analysisNeutral sphingomyelinase 2: a novel target in cigarette smoke-induced apoptosis and lung injury.Critical role of CFTR-dependent lipid rafts in cigarette smoke-induced lung epithelial injury.Critical modifier role of membrane-cystic fibrosis transmembrane conductance regulator-dependent ceramide signaling in lung injury and emphysema.Lipid Analysis of Airway Epithelial Cells for Studying Respiratory DiseasesPlasma sphingolipids associated with chronic obstructive pulmonary disease phenotypesLung cancer and lung injury: the dual role of ceramideGBA2-encoded β-glucosidase activity is involved in the inflammatory response to Pseudomonas aeruginosa.Ceramide-rich platforms in transmembrane signaling.Neutral sphingomyelinase 2 activity and protein stability are modulated by phosphorylation of five conserved serines.Potential Link between the Sphingosine-1-Phosphate (S1P) System and Defective Alveolar Macrophage Phagocytic Function in Chronic Obstructive Pulmonary Disease (COPD).Involvement of ceramide in cell death responses in the pulmonary circulation.Antenatal inflammation reduces expression of caveolin-1 and influences multiple signaling pathways in preterm fetal lungs.Ultraperformance convergence chromatography-high resolution tandem mass spectrometry for lipid biomarker profiling and identification.Sphingosine-1-phosphate, FTY720, and sphingosine-1-phosphate receptors in the pathobiology of acute lung injury.Plasma sphingolipids and lung cancer: a population-based, nested case-control study.Neutral sphingomyelinase-2, acid sphingomyelinase, and ceramide levels in COPD patients compared to controlsFingolimod for the treatment of relapsing multiple sclerosis.The role of sphingolipids in respiratory disease.The role of hypoxia in pulmonary vascular diseases: a perspective.Lipid-lowering drug therapies and chronic obstructive pulmonary disease: lung failure or just heart failure?Novel therapeutic roles for surfactant-inositols and -phosphatidylglycerols in a neonatal piglet ARDS model. A translational study.Emerging concepts in smooth muscle contributions to airway structure and function: implications for health and disease.S1P(4) receptor mediates S1P-induced vasoconstriction in normotensive and hypertensive rat lungs.Sphingomyelin metabolism in erythrocyte membrane in asthma.
P2860
Q26826812-D2B32AE0-8C38-4503-B6B3-38629219BC7EQ28084945-6E33B07D-9211-4267-AE75-52B46C0B7A8AQ28288034-FC4E266E-020B-443F-8F54-5C6E45DC9D72Q28817762-901BCE7C-880A-443C-8929-773C0078CE29Q33586246-24107372-0842-4DEF-8418-3AB4DDC1ED71Q33773550-E89BB94E-A6CC-47E9-A051-39FD3FD78E0BQ33994615-B26417A7-816C-4213-9503-3B77B879B644Q34026300-5FC0F141-DF00-4259-B46C-CFD7EF2EDB27Q34104798-AADA9EA7-D60E-4B87-81EF-F999AC032F00Q34248775-1583B838-FE2F-40C0-A9B3-C962DE2ACF46Q34305586-1F88977C-2041-41C7-BA3C-84BE7568E01EQ34310766-7A4C4E40-0688-47C0-91C0-C5716D4994F9Q34330398-F5425258-6776-4386-BA1B-D2CB3C9EA7F6Q34357097-5D2DFD8E-368A-4792-95BB-197B624BF05BQ34432733-1BEDB166-B254-48B7-9989-D31ED056FD35Q34502201-A64E03D0-1BB0-4521-94B9-47E98EBAE230Q34985463-5DD48AD1-C3B2-43BB-8A7E-44E2B2693C98Q35057070-33F04F73-E76F-4116-B7FA-44304C4F0837Q35059259-EC6355A6-19C6-4145-BB3F-04019FA91949Q35138292-DCEE9603-4783-49C0-8E4F-3A430B2974F3Q35153443-35A25182-C6B6-4FBE-81CC-3EB178D3CF70Q35207787-83D56873-64AC-4ABB-A0A7-CDBED2B7E8F4Q35228672-553F12EA-0D44-4F93-B0CD-2193FEF50B9FQ35633883-C5AEB58A-82DA-4B37-8F54-C47870CD8DEDQ35643759-51D18CF6-EB17-46CA-AFFA-A69EDD71C704Q35814901-5D2A60EB-5CAF-420F-BA39-523DC827DD14Q35983863-419DA43A-48D4-4272-A1A5-6DF7366D5A20Q35991319-E0D3AB47-0AE1-40D4-8ABB-ACB6B50BCACFQ36111836-5B88C41C-DF45-473B-8ED1-783F6608C05EQ37056490-4CA6B850-BCF1-48DF-922F-030C723937D0Q37069137-7B0B12C9-B464-48E7-ACFD-E1EE7D5E4246Q37248481-1FC92AF6-CC90-45D9-8E9B-2BB7ED5961A3Q37821010-8531E408-B2A5-492A-94A5-B5F9DEE251F5Q37928817-B6549A59-BE3A-46A7-9930-187687FBFA19Q38078782-D2E8594A-6B3A-4B02-97A9-5CFFF92B8AE9Q38181583-60598E19-731B-4A30-943B-47C085808FA6Q38634777-0A44511D-AD0D-4B44-9B25-AD734D56814FQ38811516-4B3BFE6A-BC94-4944-BF79-053E376BF0A1Q39385289-820373CA-32CF-4146-A826-B24BFA7587F9Q42835522-FC4BB335-D0B5-4139-BFA3-7D56831722BB
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Sphingolipids in the lungs.
@en
Sphingolipids in the lungs.
@nl
type
label
Sphingolipids in the lungs.
@en
Sphingolipids in the lungs.
@nl
prefLabel
Sphingolipids in the lungs.
@en
Sphingolipids in the lungs.
@nl
P2860
P1476
Sphingolipids in the lungs
@en
P2093
Stefan Uhlig
P2860
P304
P356
10.1164/RCCM.200804-595SO
P407
P577
2008-08-28T00:00:00Z